BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Snaith B, Harris MA, Shinkins B, Messenger M, Lewington A, Jordaan M, Spencer N. Point of care creatinine testing in diagnostic imaging: A feasibility study within the outpatient computed tomography setting. Eur J Radiol 2019;112:82-7. [PMID: 30777224 DOI: 10.1016/j.ejrad.2019.01.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Corbett M, Duarte A, Llewellyn A, Altunkaya J, Harden M, Harris M, Walker S, Palmer S, Dias S, Soares M. Point-of-care creatinine tests to assess kidney function for outpatients requiring contrast-enhanced CT imaging: systematic reviews and economic evaluation. Health Technol Assess 2020;24:1-248. [PMID: 32840478 DOI: 10.3310/hta24390] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
2 Duarte A, Walker S, Altunkaya J, Dias S, Corbett M, Llewellyn A, Harris MA, Palmer S, Soares M. Cost-effectiveness of point-of-care creatinine testing to assess kidney function prior to contrast-enhanced computed tomography imaging. Eur J Radiol 2021;142:109872. [PMID: 34339953 DOI: 10.1016/j.ejrad.2021.109872] [Reference Citation Analysis]
3 Bjällmark A, Bazzi M, Karlsson M, Krakys E, Kihlberg J. Radiology departmental policy compliance with Swedish guidelines regarding post-contrast acute kidney injury for examinations with iodinated contrast media. Radiography (Lond) 2021:S1078-8174(21)00048-1. [PMID: 34023227 DOI: 10.1016/j.radi.2021.04.009] [Reference Citation Analysis]
4 Currin S, Gondwe M, Mayindi N, Chipungu S, Khoza B, Khambule L, Snyman T, Tollman S, Fabian J, George J; ARK Consortium. Evaluating chronic kidney disease in rural South Africa: comparing estimated glomerular filtration rate using point-of-care creatinine to iohexol measured GFR. Clin Chem Lab Med 2021;59:1409-20. [PMID: 33711217 DOI: 10.1515/cclm-2020-1882] [Reference Citation Analysis]
5 González Cervantes JJ, Mascarós Martínez JM, Arana E. Administration of iodinated contrast: What is the risk in cancer patients? Eur J Cancer Care (Engl) 2021;30:e13351. [PMID: 33135211 DOI: 10.1111/ecc.13351] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Shinkins B, Harris M, Lewington A, Abraham S, Snaith B. Kidney function testing prior to contrast-enhanced CT: a comparative cost analysis of a personalised risk-stratified pathway versus a test all approach. Clin Radiol 2021;76:202-12. [PMID: 33109348 DOI: 10.1016/j.crad.2020.09.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Nichols JH, Alter D, Chen Y, Isbell TS, Jacobs E, Moore N, Shajani-yi Z. AACC Guidance Document on Management of Point-of-Care Testing. The Journal of Applied Laboratory Medicine 2020;5:762-87. [DOI: 10.1093/jalm/jfaa059] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
8 Stojkovic V, Delanaye P, Collard G, Ferrante N, Le Goff C, Lutteri L, Cavalier E. Estimated glomerular filtration rate using a point of care measure of creatinine in patients with iohexol determinate GFR. Clinica Chimica Acta 2019;499:123-7. [DOI: 10.1016/j.cca.2019.08.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]